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Understanding the geographic distribu-
tion of microbial pathogens such as
Mycobacterium tuberculosis, Salmonella spp.,
or Staphylococcus aureus is critical to devel-
oping strategies to reduce their transmis-
sion. Varied approaches have been used to
track their spread including the use of
national surveillance networks, multina-
tional strain collections, or more targeted
strategies that track social networks within
high-risk populations [1–4]. The integra-
tion of molecular techniques with these
surveillance strategies helps identify spe-
cific bacterial strains or clones and poten-
tially provides further insight into strain
transmission and virulence.
For S. aureus, understanding the trans-
mission pathways of the different clones
remains of critical importance. In the past
10 years the number of antibiotic-resistant
staphylococci has increased both in the
health care setting and in the community
[5–7]. Despite the availability of effective
antimicrobials, invasive S. aureus infections
continue to cause significant morbidity
and mortality. This burden of disease was
highlighted in a recent report from the
United States that estimated the overall
incidence of invasive methicillin-resistant
S. aureus (MRSA) infections at 31.8 per
100,000 and the overall mortality from
these infections at 6.3 per 100,000 [8].
Understanding the epidemiology of
these infections, the role of specific strains
and the basis for their spread has therefore
continued to be an area of intense interest.
Earlier studies have shown that, since the
first report of a methicillin-resistant staph-
ylococcus in 1961, only a limited number
of MRSA clones have been responsible for
the bulk of infections worldwide suggesting
that these unique clones have a survival
advantage [9,10]. Learning how these
clones spread, target selected populations,
and cause disease will provide insight into
understanding the basis for their remark-
able persistence and virulence.
A New Study on the Spatial
Distribution of S. aureus
In a new study by Hajo Grundmann
and colleagues in this issue of PLoS
Medicine, the investigators describe the
development of an interactive tool for
analyzing the spatial distribution of inva-
sive S. aureus [11]. The authors assembled
a large group of collaborators throughout
much of Europe including 450 hospitals
from 26 countries. They then standardized
strain collection and typing procedures.
This arduous start-up process is likely to
provide payoffs well beyond this initial
study. Over a 6-month period, from 2006–
2007, participating hospitals provided five
successive methicillin-resistant and methi-
cillin-susceptible S. aureus (MSSA) isolates
collected from patients with invasive
infections. Most of these isolates were
from bacteremias. These isolates were
characterized using a sequence-based ap-
proach, spa typing (based on the polymor-
phic protein A gene that is uniformly
found in S. aureus), which allows for
identification of specific strains. The strain
spa types were assigned to their original
hospital collection site and the spatial
analytic tools were then used to map
common spa types both by their regional
proximity and their country of origin.
Not surprisingly the authors found that
the MSSA isolates were more varied and
more widely dispersed than the MRSA
isolates. The latter were more geographi-
cally limited and had fewer clonal types.
The MRSA spa types tended to mostly
cluster within regional borders and, in
several instances, were associated with
individual hospitals, suggesting an out-
break. The authors provide an interactive
map that allows others to query the web site
for the location of particular clones and to
examine the distribution throughout Eur-
ope of the different strains (http://www.
spatialepidemiology.net/SRL-Maps).
The study has some limitations, many
already noted by the authors. There was a
potential selection bias given the reduced
number of MRSA versus MSSA isolates.
In an effort to identify specific strains with
enhanced virulence, the authors linked
strain profiles with all-cause mortality at
2 weeks. While no association was found,
all-cause mortality is a relatively crude
indicator and may miss factors contribut-
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Linked Research Article
This Perspective discusses the fol-
lowing new study published in PLoS
Medicine:
Grundmann H, Aanensen DM, van
den Wijngaard CC, Spratt BG, Harm-
sen D, et al. (2010) Geographic
Distribution of Staphylococcus aureus
Causing Invasive Infections in Eur-
ope: A Molecular-Epidemiological
Analysis. PLoS Med 7(1): e1000215.
doi:10.1371/journal.pmed.1000215
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death as an outcome. Future studies will
likely further refine this approach. Missing
data, especially on the source of the
isolates (community versus hospital), and
the all-cause mortality may have influ-
enced the analysis of this data.
What Is the Potential of This
Approach?
The major strength of Grundmann and
colleague’s proof of principle study is
that it shows the potential value of
this integrated approach. By establishing
a large collaborative network and then
combining molecular and spatial analytic
techniques, the authors illustrate the
ability to map specific strains across large
geographic regions. At its most basic, the
study provides information on whether
clones of S. aureus are randomly distributed
or clustered. The authors however also
illustrate that there are many other
potential applications of this approach.
The authors show that by linking strain
profiles with patient outcomes they can
generate information on the potential
virulence of a particular clone. In the
future, this approach could be applied to
strains isolated from the community,
strains from different tissue sites, or to
strains with or without selected virulence
genes. Sociodemographic information,
such as the age, sex, or occupation of the
patient, can be correlated with the strain
type. This information may then generate
hypotheses on transmission pathways,
susceptible high-risk occupations (e.g., pig
farmers and spa type t034 ), or particularly
vulnerable populations [12,13].
Innovative mapping strategies, based on
information provided from international
organizations, news media, and scientific
reports, have recently been used to
develop interactive maps that show the
geographic distribution of a variety of
different pathogens (e.g., see Health Map,
http://www.healthmap.org/en). Grund-
mann and colleagues’ study is one of
several recent investigations that illustrate
the ability of spatial mapping techniques
to help understand the spread of new or
reemerging pathogens at the local as well
as the international level [14,15].
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